Page last updated: 2024-10-20

pyridoxine 5-phosphate and Carcinoma, Ovarian Epithelial

pyridoxine 5-phosphate has been researched along with Carcinoma, Ovarian Epithelial in 1 studies

pyridoxine 5-phosphate: RN given refers to parent cpd

Carcinoma, Ovarian Epithelial: A malignant neoplasm that originates in cells on the surface EPITHELIUM of the ovary and is the most common form of ovarian cancer. There are five histologic subtypes: papillary serous, endometrioid, mucinous, clear cell, and transitional cell. Mutations in BRCA1, OPCML, PRKN, PIK3CA, AKT1, CTNNB1, RRAS2, and CDH1 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, L1
Zhou, D1
Guan, W1
Ren, W1
Sun, W1
Shi, J1
Lin, Q1
Zhang, J1
Qiao, T1
Ye, Y1
Wu, Y1
Zhang, Y1
Zuo, X1
Connor, KL1
Xu, G1

Other Studies

1 other study available for pyridoxine 5-phosphate and Carcinoma, Ovarian Epithelial

ArticleYear
Pyridoxine 5'-phosphate oxidase is a novel therapeutic target and regulated by the TGF-β signalling pathway in epithelial ovarian cancer.
    Cell death & disease, 2017, 12-13, Volume: 8, Issue:12

    Topics: Animals; Antagomirs; Base Sequence; Benzamides; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Cel

2017